Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01102439Phase 4Completed
Phase 4, randomised trial of clopidogrel and aspirin in coronary artery disease (CAD) (4 arms), sponsored by Population Health Research Institute. Primary endpoint: Blood concentrations of the active metabolite of clopidogrel at 14 days. Started Apr 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01102439.